Investigating binding potential of carotenoid pathway bioactive molecules for ACE۲ receptor of SARS-CoV-۲: Possibility of a saffron based remedy for novel coronavirus!
سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 80
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JHPR-4-13_007
تاریخ نمایه سازی: 6 شهریور 1402
چکیده مقاله:
Purpose: Given the rising number of novel coronavirus named SARS-CoV-۲ (COVID-۱۹) cases, the purpose of the present study was to explore saffron bioactive compounds against COVID-۱۹ since saffron is used in fever, bronchitis, cold, respiratory disorders and is recognized for its anti-inflammatory, antioxidant and immunomodulatory effects. Research method: COVID-۱۹ engages the host cell surface receptor angiotensin-converting enzyme ۲ (ACE۲) through its spike protein receptor-binding domain (RBD). The idea was to check atomistic interaction of these bioactive molecules with ACE۲ for obstructing its interaction with RBD, in order to screen and assess the likelihood of these molecules for drug development. Based on ligands' molecular weight, we chose smaller bioactive molecules (picrocrocin, safranal, lutein) for interaction with cell ACE۲ of the host. Findings: Flexible molecular docking followed by atomic level interaction study indicated that lutein and picrocrocin form various interactions with different amino acid residues of ACE۲. In depth analysis revealed that these interactions with the majority of the residues of ACE۲ could be crucial for RBD binding and, therefore, can disrupt the interaction between RBD and ACE۲. The study provides a hit for further analysis using in vitro, animal models and clinical studies. Limitations: In this study dynamic approaches such as molecular dynamics and semiemperical quantum mechanical (SQM) methods have not been used. Originality/Value: By preventing the interaction of RBD with ACE۲, lutein and picrocrocin may prove helpful in the development of therapeutics for COVID-۱۹ management.
کلیدواژه ها:
نویسندگان
Shabir Ahmad Ahmed
Division of Basic Sciences and Humanities, Faculty of Agriculture, SKUAST-K, Wadoora, Jammu & Kashmir-۱۹۳۲۰۱, India
Amjad Husaini
Genome Engineering and Societal Biotechnology Lab, Division of Plant Biotechnology, SKUAST-K, Shalimar, Jammu & Kashmir- ۱۹۰۰۲۵, India
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :